Voyager Therapeutics (VYGR) Reports Q3 Loss, Tops Revenue Estimates

Voyager Therapeutics (VYGR) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of$ 0.45. This compares to loss of $0.59 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 64.44%. A quarter ago, it was expected that this gene therapy company would post a loss of$ 0.38 per share when it actually produced a loss of $0.18, delivering a surprise of 52.63%.Over the last four quarters, the co ...